Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines
Puma Biotechnology Says NCCN Clinical Practice Adds Breast Cancer Drug Nerlynx to Guidelines
Puma Biotechnology 表示 NCCN 临床实践将乳腺癌药物 Nerlynx 添加到指南中
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册